We showed that TNF binding to site 2 induced the allosteric activation of integrins, like several other inflammatory cytokines, suggesting that allosteric integrin activation may be a potential marker of pro-inflammatory signaling and insulin resistance, and site 2 may be a potential therapeutic target. The gene discussed is TNF; the disease is Insulin resistance.